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Acute	confusion	and	ataxia	in	the	emergency	department	
with	an	unexpected	underlying	diagnosis
A 54 year old man presented to the Emergency Department 
with a one day history of  confusion and unsteadiness. He 
had been unwell in the week preceding this presentation with 
nausea, poor appetite and vomiting.
He had been diagnosed with hypertension as a teenager. He 
took anti-hypertensives intermittently and had not taken 
them for more than 6 months preceding this presentation. 
He had otherwise been well with no admissions and little 
contact with medical services. He had no history of  smoking, 
alcohol or illicit drug use. He had no other drug prescriptions 
besides Propranolol 40mg twice daily and Hydrochlorthiazide 
25mg daily. He had no history of  taking herbal medication. 
There was no family history of  hypertension.  Amongst his 
3 siblings and parents, there was no history of  sudden death 
or unexplained ill health at a young age.
On examination he had conjunctival pallor, was drowsy 
with a Glasgow Coma Score of  14/15 (E-4, M-6, V-4). 
He was noted to have “half  and half  nails”. His vital signs 
were:  blood pressure 162/88mmHg, pulse rate 124 beats/
min, respiratory rate 21 breaths/min and temperature 36.4 
°C.  The cardiovascular and respiratory examinations were 
normal.  Abdominal examination revealed a palpable bladder 
up to the level of  the umbilicus. He had no neck stiffness, 
the cranial and peripheral nerves examination was normal. 
A random blood glucose carried out in the emergency 
department was 146mg/dl and his oxygen saturations were 




2.	 What	 differential	 diagnoses	 should	 be	
considered	for	the	underlying	cause?
3.	 What	urgent	 investigations	 should	be	 carried	
out?
Answers
1. The most likely cause of  this presentation is a metabolic 
encephalopathy. He does not have  features of  acute or chronic 
liver disease making hepatic encephalopathy  unlikely. His 
blood glucose is normal and there are no pointers towards 
pulmonary disease. An infective etiology is unlikely as he 
is afebrile, has no neck stiffness and no focal neurological 
signs. However, infection cannot be completely ruled out 
at this stage. There is no history to suggest intoxication or 
poisoning. The symptoms of  nausea and vomiting, plus the 
finding of  clinical anaemia and “half  and half ” nails make 
uraemic encephalopathy most likely.
2. The differential diagnosis of  kidney failure in this 
patient needs to include renal and post-renal causes. The 
finding of  probable anaemia makes chronic or “acute on 
chronic” kidney failure most likely.  He has chronic poorly 
controlled hypertension and hypertensive kidney disease 
is a possibility. The history of  onset of  hypertension 
at a young age is unusual and raises the possibility of  a 
secondary cause of  hypertension. This may suggest that he 
has long standing kidney disease. Chronic renal conditions 
with onset in teenage years and slow progression include 
renal hypoplasia/dysplasia, glomerulonephritis and reflux 
nephropathy.The most likely cause of  acute kidney injury in 
this man is obstructive uropathy. He has a palpable bladder 
and is in the age group where urinary outflow obstruction 
due to prostate pathology is common. Other causes of  
chronic kidney disease that can present at this age include 
diabetic nephropathy, chronic use of  nephrotoxic drugs and 
multisystem diseases (myeloma, vasculitis).
3.Urgent investigations must include measurement of  urea, 
creatinine and electrolytes, urine dipstick and microscopy, 
full blood count (FBC), liver function tests,  HIV testing and 
a renal ultrasound. Blood cultures and a lumbar puncture for 
cerebrospinal fluid analysis should also be done to rule out 
infective causes of  confusion. If  these tests are unremarkable 
brain imaging should be considered.
The creatinine was 18.3mg/dL (Normal range 0.7 – 1.2mg/
dL ), potassium  8.3mmol/L (3.5 -5 mmol/L), sodium 
136mmol/L (135 – 145 mmol/L)  and chloride 103mmol/L 
(98 – 107mmol/L).  The haemoglobin concentration was 
7.3g/dL,  mean cell volume (MCV)  74 fL, white blood cells 
(WBC) 7.6×106/μL and platelets 277×106/μL. A urine 
dipstick from a catheter sample showed protein + and blood 
+++.  
The serum albumin was 3.0mg/dL and the rest of  the liver 
function tests were normal. The HIV test was negative. 
Cerebrospinal fluid analysis revealed no WBC, 190 red cells/
hpf  (the lumbar puncture was traumatic), normal glucose and 
protein, India Ink stain negative and no growth on culture. 
Magnetic resonance imaging of  the brain was normal.
An urgent abdominal ultrasound scan carried out before 
catheterization showed a grossly distended bladder but 
with normal bladder wall thickness, suggesting acute 
urine retention and a normal prostate. Both kidneys were 
enlarged with multiple bilateral kidney cysts. There was no 
hydronephrosis . There were no cysts in the liver.
Final diagnosis: Acute on chronic kidney injury due to 
urinary retention on a background of  chronic kidney disease 
secondary to adult polycystic kidney disease. 
Further	Progress
Hyperkalaemia of  this magnitude is a medical emergency. He 
was immediately treated with intravenous calcium gluconate 
and intravenous insulin and dextrose. The hyperkalemia 
did not respond to initial management  and he was 
subsequently referred for urgent haemodialysis for refractory 
hyperkalaemia and suspected uraemic encephalopathy.  
After 3 haemodialysis treatments via a temporary dialysis 
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catheter in the right femoral vein, the encephalopathy resolved 
and the creatinine and potassium levels fell (see table 1). He 
maintained a good urinary output throughout the course of  
admission (40 – 60cc/hr) after bladder catheterisation.  
The patient was discharged and followed as an outpatient. 
Over the next 2 months, his renal function deteriorated 
and he became progressively uraemic.   He was eventually 
started on regular twice weekly haemodialysis sessions via 
a semi permanent internal jugular haemodialysis catheter. 
Five months after the initiation of  dialysis, the patient had 
an episode of  fever and massive hemoptysis for which 
the underlying cause was not clear.  Despite aggressive 
resuscitation, intubation and admission to the intensive care 
unit, he died in August 2012.
Discussion
Acute	Confusion	and	Uraemic	Encephalopathy
In both acute and chronic kidney disease, encephalopathy 
may result from uraemia and drug toxicities. The severity 
and progression of  uraemic encephalopathy depends on the 
rate of  decline of  kidney function and not necessarily on the 
absolute creatinine or blood urea nitrogen levels.  Symptoms 
are usually reversible with dialysis.
The mechanism of  uraemic encephalopathy is multifactorial 
and is thought to result from hormonal imbalances, the 
accumulation of  uraemic toxins and oxidative stress2. 
Acute presentations of  autosomal dominant polycystic 
kidney disease to the emergency department are rare but have 
been described with features such as vomiting, abdominal 
pain and kidney failure3.
Autosomal	Dominant	Polycystic	Kidney	Disease
Background
Autosomal dominant polycystic kidney disease (ADPKD) 
is an inherited disorder that affects all races equally with 
an estimated worldwide prevalence of  1 in 800 live births3. 
The responsible genes lie on chromosome 16 (PKD1 gene) 
accounting for 85% of  ADPKD cases and chromosome 4 
(PKD2 gene) accounting for 15% of  ADPKD cases4. 
Offspring of  affected parents have 50% risk of  inheritance 
each but in up to a fourth of  newly diagnosed cases, patients 
report no familial history of  the disease suggesting that 
many cases go undetected5 or that spontaneous mutations 
may occur.
Presentation
Kidney manifestations include enlarged kidneys with fluid 
filled cysts, haematuria, proteinuria, nephrolithiasis and flank 
pain. Kidney failure characteristically appears in between the 
fourth and sixth decades of  life4
Cysts can occur anywhere along the nephron and are thought 
to result from an imbalance between cellular proliferation and 
apoptosis2. Cysts can rupture spontaneously or secondary 
to trauma into the kidney tubules causing hematuria. They 
may also become secondarily infected7. ADPKD is also 
associated with high circulating vasopressin levels and 
vasopressin resistance.
Hypertension occurs in 60% of  ADPKD patients before 
any significant glomerular filtration rate (GFR) decline 
and results from activation of  a local intra-kidney renin 
angiotensin aldosterone system as a result of  ischaemia from 
expanding kidney cysts4,6. 
Cysts can also occur in the liver (60% of  APKD patients), 
seminal vesicles, pancreas and arachnoid membrane3,4. 
Hepatic cysts are more common in women but are not 
known to cause liver failure.
Other extra-renal manifestations include intracranial 
aneurysms, mitral valve prolapse and diverticulosis. The risk 
of  aneurysm rupture increases with a prior or family history 
of  ruptured aneurysm4,5.
Diagnosis
Kidney sonography is most commonly used to diagnose 
ADPKD. Diagnostic criteria include at least two unilateral or 
bilateral cysts in individuals younger than 30 years; two cysts 
in each kidney in individuals 30–59 years; and four cysts in 
each kidney in individuals 60 years or older3. CT Scan and 
MRI may also be used. The use of  genetic testing is limited 
by hundreds of  intragenic PKD1 and PKD2 mutations.
Differential	Diagnosis
Other polycystic kidney disorders include inherited 
conditions such as familial nephronophthosis and medullary 
cystic kidneys both of  which are characterized by bilateral 
small kidneys, salt wasting and polyuria. Autosomal recessive 
polycystic kidney disease is much rarer than ADPKD and 
often causes fetal and neonatal deaths due to tremendous 
bilateral kidney enlargement, impaired lung function and 
pulmonary hypoplasia3. Acquired cysts may develop as a 
result of  aging and dialysis.
Management
Antihypertensives are recommended for adults with 
hypertension with target BP 130/80mmHg particularly with 
angiotensin converting enzyme inhibitors or angiotensin 
receptor blockers which have been shown to preserve kidney 
function in APKD7. More recently, a study on vasopressor 
receptor antagonist drugs demonstrated reduction in the 
decline of  kidney function and slowed progression of  total 
kidney volume when tolvaptan was compared to placebo in 
APKD patients9.
Infected kidney or hepatic cysts may require prolonged 
antibiotic therapy or drainage.  Haematuria is often managed 
conservatively with hydration and bed rest. Flank pain is 
managed with analgesics avoiding nephrotoxic agents5.
ADPKD patients progressing to end-stage kidney disease 
require renal replacement therapy which includes dialysis 
and kidney transplantation. Transplantation, when possible, 
is the treatment of  choice4.
The above case illustrates an unusual presentation of  
confusion with an unexpected underlying diagnosis.  Kidney 
disease should be considered as a metabolic cause of  acute 
confusion and renal function tests should be obtained in all 
such cases.  
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Table 1: Serial Electrolytes Pre- and Post-hemodialysis
Date 20/3/12
   (admission)
28/3/12
(after 2nd dialysis session)
31/3/12
(after 3rd dialysis session)
3/4/12
(on discharge)
Creatinine (mg/dL)* 18.39 9.43 13.6
Potassium (mmol/L) 8.3 4 3.6 5.0
Sodium  (mmol/L) 137 137 142 137
Chloride (mmol/L) 103 104 104 97






*normal values for Creatinine (0.7 – 1.2mg/dL ), Potassium   (3.5 -5 mmol/L),  Sodium(135 – 145 mmol/L)  and Chloride  (98 – 
107mmol/L), Urea (8 – 25mg/dL), Phosphate: ( 0.81 – 1.45 mmol/L), (Bicarbonate (22-31mmol/L), Calcium (2.1 -2.5) 
